Logo image of EVAX

EVAXION A/S (EVAX) Stock Overview

NASDAQ:EVAX - US29970R3030 - ADR

2.75 USD
-0.29 (-9.69%)
Last: 8/29/2025, 8:18:58 PM
2.75 USD
0 (0%)
After Hours: 8/29/2025, 8:18:58 PM

EVAX Key Statistics, Chart & Performance

Key Statistics
52 Week High17.75
52 Week Low1.2
Market Cap17.37M
Shares6.32M
Float4.86M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-4.22
PEN/A
Fwd PEN/A
Earnings (Next)10-29 2025-10-29
IPO02-05 2021-02-05
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


EVAX short term performance overview.The bars show the price performance of EVAX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30 40

EVAX long term performance overview.The bars show the price performance of EVAX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EVAX is 2.75 USD. In the past month the price increased by 5.36%. In the past year, price decreased by -81.97%.

EVAXION A/S / EVAX Daily stock chart

EVAX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.68B
AMGN AMGEN INC 13.19 154.89B
GILD GILEAD SCIENCES INC 14.6 140.17B
VRTX VERTEX PHARMACEUTICALS INC 23.08 100.25B
REGN REGENERON PHARMACEUTICALS 12.72 61.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.53B
ARGX ARGENX SE - ADR 76.83 43.59B
ONC BEONE MEDICINES LTD-ADR 6.16 36.38B
INSM INSMED INC N/A 28.77B
BNTX BIONTECH SE-ADR N/A 24.04B
NTRA NATERA INC N/A 23.09B
BIIB BIOGEN INC 8.26 19.38B

About EVAX

Company Profile

EVAX logo image Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Company Info

EVAXION A/S

Dr. Neergaards Vej 5F

Hoersholm 1260 DK

CEO: Lars Staal Webner

Employees: 46

EVAX Company Website

EVAX Investor Relations

EVAXION A/S / EVAX FAQ

What is the stock price of EVAXION A/S today?

The current stock price of EVAX is 2.75 USD. The price decreased by -9.69% in the last trading session.


What is the ticker symbol for EVAXION A/S stock?

The exchange symbol of EVAXION A/S is EVAX and it is listed on the Nasdaq exchange.


On which exchange is EVAX stock listed?

EVAX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for EVAXION A/S stock?

8 analysts have analysed EVAX and the average price target is 6.12 USD. This implies a price increase of 122.55% is expected in the next year compared to the current price of 2.75. Check the EVAXION A/S stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EVAXION A/S worth?

EVAXION A/S (EVAX) has a market capitalization of 17.37M USD. This makes EVAX a Nano Cap stock.


How many employees does EVAXION A/S have?

EVAXION A/S (EVAX) currently has 46 employees.


What are the support and resistance levels for EVAXION A/S (EVAX) stock?

EVAXION A/S (EVAX) has a support level at 2.74 and a resistance level at 3.05. Check the full technical report for a detailed analysis of EVAX support and resistance levels.


Is EVAXION A/S (EVAX) expected to grow?

The Revenue of EVAXION A/S (EVAX) is expected to decline by -100% in the next year. Check the estimates tab for more information on the EVAX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EVAXION A/S (EVAX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EVAXION A/S (EVAX) stock pay dividends?

EVAX does not pay a dividend.


When does EVAXION A/S (EVAX) report earnings?

EVAXION A/S (EVAX) will report earnings on 2025-10-29.


What is the Price/Earnings (PE) ratio of EVAXION A/S (EVAX)?

EVAXION A/S (EVAX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.22).


What is the Short Interest ratio of EVAXION A/S (EVAX) stock?

The outstanding short interest for EVAXION A/S (EVAX) is 2.43% of its float. Check the ownership tab for more information on the EVAX short interest.


EVAX Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to EVAX. When comparing the yearly performance of all stocks, EVAX is a bad performer in the overall market: 94.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

EVAX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to EVAX. EVAX has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EVAX Financial Highlights

Over the last trailing twelve months EVAX reported a non-GAAP Earnings per Share(EPS) of -4.22. The EPS increased by 76.02% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -53.34%
ROE -192.34%
Debt/Equity 1.73
Chartmill High Growth Momentum
EPS Q2Q%96.67%
Sales Q2Q%-75.97%
EPS 1Y (TTM)76.02%
Revenue 1Y (TTM)1042.45%

EVAX Forecast & Estimates

8 analysts have analysed EVAX and the average price target is 6.12 USD. This implies a price increase of 122.55% is expected in the next year compared to the current price of 2.75.

For the next year, analysts expect an EPS growth of 18.95% and a revenue growth -100% for EVAX


Analysts
Analysts82.5
Price Target6.12 (122.55%)
EPS Next Y18.95%
Revenue Next Year-100%

EVAX Ownership

Ownership
Inst Owners2.16%
Ins Owners0.68%
Short Float %2.43%
Short Ratio1.05